Cart is empty
View Cart
Subtotal: $0.00
JOIN NOW!
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • EDEI Committee
      • Education
      • Emerging Leaders
      • Local GAMP CoP
      • Membership
      • Product Show
      • Social
      • Student Development
      • Women in Pharma®
    • Students
      • Student Chapters
      • Career Workshop
      • Scholarships
    • Chapter Awards
      • NEW Chapter Awards 2024
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
    • Educational Programs
    • Social Events
    • Student Activities
    • Product Show
    • Past Events
  • RESOURCES
    • Scholarship Foundation
      • Scholarship Application
    • Podcast
    • Documents
    • Chapter YouTube Channel
    • ISPE Publications
    • ISPE Guidance Documents
    • Member Directory
    • ISPE Training
    • ISPE Communities of Practice
  • BLOG
    • Boston Chapter Blog
      • Contribute
    • ISPE Blog
  • CAREERS
    • Job Board
    • Post a Job
  • Gallery
  • SCHOLARSHIP FOUNDATION
    • About the Foundation
    • Apply for a Scholarship
    • Donate
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • EDEI Committee
      • Education
      • Emerging Leaders
      • Local GAMP CoP
      • Membership
      • Product Show
      • Social
      • Student Development
      • Women in Pharma®
    • Students
      • Student Chapters
      • Career Workshop
      • Scholarships
    • Chapter Awards
      • NEW Chapter Awards 2024
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
    • Educational Programs
    • Social Events
    • Student Activities
    • Product Show
    • Past Events
  • RESOURCES
    • Scholarship Foundation
      • Scholarship Application
    • Podcast
    • Documents
    • Chapter YouTube Channel
    • ISPE Publications
    • ISPE Guidance Documents
    • Member Directory
    • ISPE Training
    • ISPE Communities of Practice
  • BLOG
    • Boston Chapter Blog
      • Contribute
    • ISPE Blog
  • CAREERS
    • Job Board
    • Post a Job
  • Gallery
  • SCHOLARSHIP FOUNDATION
    • About the Foundation
    • Apply for a Scholarship
    • Donate
Featured Image

VC Firm Launches $824 Million Funding Effort

  • Posted by ISPE Boston
  • On March 22, 2019
Cambridge-based Flagship Pioneering has announced that it has secured $824 million to support the growth of human health and sustainability companies originated by its Flagship Labs unit. The new capital pool will operate alongside more than $700 million in capital raised in late 2017 and 2018 that currently finances Flagship’s in-house innovation and company origination […]
Read More
 
Featured Image

Sage Therapeutics Wins FDA Approval of Drug for Postpartum Depression

  • Posted by ISPE Boston
  • On March 20, 2019
Sage Therapeutics, a biopharmaceutical company developing novel medicines to treat life-altering central nervous system disorders, has announced that the FDA has approved ZulressoTM (brexanolone) injection for the treatment of postpartum depression (PPD). Zulresso is the first and only medicine specifically approved to treat PPD, the most common medical complication of childbirth. Zulresso is expected to […]
Read More
 
Featured Image

Karuna Announces $68 Million Series B Financing

  • Posted by ISPE Boston
  • On March 20, 2019
Boston-based Karuna Therapeutics, focused on the treatment of neuropsychiatric disorders including psychosis in schizophrenia, psychosis in Alzheimer’s disease, and pain, has announced the completion of a $68 million Series B financing round, including the issuance of $5 million in shares upon conversion of debt into equity. KarXT, Karuna’s lead product candidate, is currently being evaluated […]
Read More
 
Featured Image

Biotech Supplier HPNE Leases Former Alexion Facility

  • Posted by ISPE Boston
  • On March 12, 2019
High Purity New England, a supplier of biotech equipment, has signed a lease for a substantial new building, formerly occupied by Alexion, where they will nearly quadruple their manufacturing footprint and expand their offices in northern Rhode Island. High Purity New England has seen a surge of growth in the past 6 years, having grown […]
Read More
 
Featured Image

Voyager Therapeutics and AbbVie Announce Collaboration

  • Posted by ISPE Boston
  • On March 6, 2019
Voyager Therapeutics and AbbVie have announced an exclusive, global strategic collaboration and option agreement to develop and commercialize vectorized antibodies for the potential treatment of Parkinson’s disease and other diseases (synucleinopathies) characterized by the abnormal accumulation of misfolded alpha-synuclein protein. The delivery of sufficient quantities of antibodies across the blood-brain barrier is one of the […]
Read More
 
Featured Image

Biogen to Acquire Gene Therapy Company Nightstar Therapeutics

  • Posted by ISPE Boston
  • On March 6, 2019
Biogen has announced plans to acquire Nightstar Therapeutics (NST), a clinical-stage gene therapy company based in London, UK. NSK is focused on adeno-associated virus (AAV) treatments for inherited retinal disorders. Under the terms of the proposed acquisition, Biogen will pay $25.50 in cash for each NSK share, representing a total transaction value of about $800 […]
Read More
 
Featured Image

Voyager Therapeutics and Neurocrine Biosciences to Collaborate on Parkinson’s Disease

  • Posted by ISPE Boston
  • On February 14, 2019
Cambridge-based Voyager Therapeutics and Neurocrine Biosciences  and have announced the formation of a strategic collaboration focused on the development and commercialization of Voyager’s gene therapy programs for Parkinson’s disease and Friedreich’s ataxia, as well as rights to two programs to be determined. This collaboration combines Neurocrine Biosciences’ expertise in neuroscience, drug development and commercialization with […]
Read More
 
Featured Image

Ironwood and Cyclerion Name Women to Chair Boards

  • Posted by ISPE Boston
  • On January 28, 2019
The separation of Ironwood Pharmaceuticals into two independent, publicly traded companies, Ironwood and Cyclerion Therapeutics, first announced in May 2018, is on track to be completed during the first half of 2019; and both companies have named women to lead their new boards of directors. Julie McHugh will serve as chair of the new Ironwood […]
Read More
 
Featured Image

Ironwood, Cyclerion CEOs Named as Split Moves Forward

  • Posted by ISPE Boston
  • On January 28, 2019
The separation of Ironwood Pharmaceuticals into two independent, publicly traded companies, first announced in May 2018, is on track to be completed during the first half of 2019. In early January, Ironwood announced the appointment of the CEOs of the two companies, to become effective at the time of the separation. Industry veteran Mark Mallon […]
Read More
 
Featured Image

Kyn Therapeutics and Celgene to Develop Immuno-oncology Therapies

  • Posted by ISPE Boston
  • On January 25, 2019
Kyn Therapeutics, a Boston-based, clinical-stage biotech launched in December 2017 has announced a global strategic collaboration with Celgene to develop novel immuno-oncology therapies. The collaboration unites Kyn’s immuno-oncology expertise and pipeline with Celgene’s capabilities for developing and commercializing medicines in areas of high unmet medical need. It gives Celgene exclusive options to license Kyn’s aryl […]
Read More
 
Page 44 of 56«‹4243444546›»
Post Categories
  • Podcasts (1)
  • Industry Buzz (557)
  • Chapter News (536)
  • Knowledge & Training (79)
  • Students & YP (78)
  • Career Tools (13)
Get Updates via Email




Scroll
Follow Us
Search this Site
@2024 ISPE Boston Chapter. All rights reserved.